Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Taking a Number of Medications Regularly Could Give You a Serious Headache

11.11.2004


If you frequently take over-the-counter pills or prescription medication to make your headaches go away, you might get relief—temporarily. But the frequent use of headache medications to make the pain of a headache disappear could trigger chronic daily headache (CDH), according to recent commentary appearing in Headache Currents. Numerous studies have highlighted similar conclusions about the overuse of medication, giving further weight to the expert opinions from Drs Fred Sheftell and Marcello Bigal of the New England Center for Headache.



Headache Currents, a joint publication of the American Headache Society and Blackwell Publishing, just released this commentary on recent articles documenting the evidence that suggests that medication overuse is associated with CDH Sheftell and Bigal recommend that physicians need to address this with their patients by carefully examining their medical and medication history, and patients should seek medical help if they are taking pills multiple times a week on a regular basis.

“Physicians and patients need to be educated in the phenomenon of medication-overuse headaches (MOH),” says Dr Sheftell. Sheftell previously wrote an article on the negligence of the FDA and FTC in this matter, because they do not currently mandate that over-the-counter products address the dangers of overmedication, adverse events, or contra-indications in their labeling or advertising.


“Chronic daily headache is a debilitating and difficult problem to treat, often requiring specialty center care,” added Sheftell. According to the International Headache Society, CDH affects about 3 to 5% of the general population and 70 to 80% in specialty care settings, making it one of the most frequently encountered headache disorders seen in the specialty care setting. The burden of CDH-related disability is substantial and is associated with a significantly diminished health-related quality of life, decreased physical, social and occupational functioning, and worsened mental health.

Sharon Agsalda | alfa
Further information:
http://www.blackwellpublishing.com/hec

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

More genes are active in high-performance maize

19.01.2018 | Life Sciences

How plants see light

19.01.2018 | Life Sciences

Artificial agent designs quantum experiments

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>